Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT05535946
Registration number
NCT05535946
Ethics application status
Date submitted
7/09/2022
Date registered
10/09/2022
Date last updated
7/08/2024
Titles & IDs
Public title
ABTECT - Maintenance
Query!
Scientific title
A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Query!
Secondary ID [1]
0
0
ABX464-107
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Ulcerative Colitis
0
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
0
0
0
0
Query!
Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Query!
Inflammatory and Immune System
0
0
0
0
Query!
Other inflammatory or immune system disorders
Query!
Oral and Gastrointestinal
0
0
0
0
Query!
Inflammatory bowel disease
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - ABX464
Treatment: Drugs - Placebo
Placebo comparator: ABX464 50mg - Responder subjects at the end of induction - Subjects will be orally dosed during 44 weeks
Placebo comparator: ABX464 25mg - Responder subjects at the end of induction - Subjects will be orally dosed during 44 weeks
Placebo comparator: Placebo - Responder subjects at the end of induction - Subjects will be orally dosed during 44 weeks
Experimental: ABX464 50mg - Non responder subjects at the end of induction - Subjects will be orally dosed during 44 weeks
Experimental: ABX464 25mg - Non responder subjects at the end of induction - Subjects will be orally dosed during 44 weeks
Experimental: Long Term Extension - At the end of the maintenance phase (week 44), subjects can continue their allocated treatment for up to 4 years. Once the maintenance phase is unblinded, subjects receiving placebo in the maintenance phase will be allocated to obefazimod 25 mg or can terminate the study.
Treatment: Drugs: ABX464
Administered once daily, preferably in the morning, with food
Treatment: Drugs: Placebo
Administered once daily, preferably in the morning, with food
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Rate of subjects in clinical remission at Week 44
Query!
Assessment method [1]
0
0
The Part 1 primary objective is to compare the efficacy of ABX464 versus placebo on the proportion of subjects in clinical remission \[SFS = 0 or 1, RBS = 0 and endoscopy sub-score = 0 or 1\] at Week 44.
Query!
Timepoint [1]
0
0
Week 44
Query!
Primary outcome [2]
0
0
Number and percentage of all treatment-emergent adverse events (TEAEs)
Query!
Assessment method [2]
0
0
The Part 2 primary objective is safety
Query!
Timepoint [2]
0
0
Week 44
Query!
Primary outcome [3]
0
0
Number and percentage of all serious adverse events (SAEs)
Query!
Assessment method [3]
0
0
The Part 2 primary objective is safety
Query!
Timepoint [3]
0
0
Week 44
Query!
Primary outcome [4]
0
0
Number and percentage of all causally related TEAEs/SAEs
Query!
Assessment method [4]
0
0
The Part 2 primary objective is safety
Query!
Timepoint [4]
0
0
Week 44
Query!
Secondary outcome [1]
0
0
Proportion of subjects with endoscopic improvement at Week 44
Query!
Assessment method [1]
0
0
To compare the efficacy of ABX464 versus placebo on endoscopic improvement (Mayo Endoscopic Subscore (MES) = 0 or 1) at Week 44
Query!
Timepoint [1]
0
0
Week 44
Query!
Secondary outcome [2]
0
0
Proportion of subjects with corticosteroid-free clinical remission
Query!
Assessment method [2]
0
0
To compare the efficacy of ABX464 versus placebo on corticosteroid-free clinical remission (clinical remission at Week 44 and corticosteroid free for at least 12 weeks prior to Week 44 in the subpopulation with corticosteroids at maintenance study entry)
Query!
Timepoint [2]
0
0
Week 44
Query!
Secondary outcome [3]
0
0
Proportion of subjects with sustained clinical remission at Week 44
Query!
Assessment method [3]
0
0
To compare the efficacy of ABX464 versus placebo to sustain clinical remission at Week 44
Query!
Timepoint [3]
0
0
Week 44
Query!
Secondary outcome [4]
0
0
Proportion of subjects with HEMI per Geboes scoring at Week 44
Query!
Assessment method [4]
0
0
To evaluate the efficacy of ABX464 on histologic-endoscopic mucosal improvement (HEMI) versus placebo at Week 44
Query!
Timepoint [4]
0
0
Week 44
Query!
Secondary outcome [5]
0
0
Proportion of subjects with endoscopic remission at Week 44
Query!
Assessment method [5]
0
0
To compare the efficacy of ABX464 versus placebo on endoscopic remission (MES = 0) at Week 44
Query!
Timepoint [5]
0
0
Week 44
Query!
Secondary outcome [6]
0
0
LTE Phase - Proportion of subjects in clinical remission at Year 1
Query!
Assessment method [6]
0
0
To evaluate the efficacy of obefazimod on clinical remission \[SFS = 0 or 1, RBS = 0 and endoscopy sub-score = 0 or 1\] at Year 1
Query!
Timepoint [6]
0
0
LTE Year 1
Query!
Secondary outcome [7]
0
0
LTE Phase - Proportion of subjects in clinical remission at Year 4
Query!
Assessment method [7]
0
0
To evaluate the efficacy of obefazimod on clinical remission \[SFS = 0 or 1, RBS = 0 and endoscopy sub-score = 0 or 1\] at Year 4
Query!
Timepoint [7]
0
0
LTE Year 4
Query!
Secondary outcome [8]
0
0
LTE Phase - Proportion of subjects with corticosteroid-free clinical remission in the subpopulation with corticosteroids at maintenance study entry
Query!
Assessment method [8]
0
0
To evaluate the efficacy of obefazimod on CS-free clinical remission (clinical remission at Year 1 and corticosteroid free for at least 12 weeks prior to Year 1 in the subpopulation with corticosteroids at maintenance study entry)
Query!
Timepoint [8]
0
0
LTE Year 1
Query!
Secondary outcome [9]
0
0
LTE Phase - Proportion of subjects with corticosteroid-free clinical remission in the subpopulation with corticosteroids at maintenance study entry)
Query!
Assessment method [9]
0
0
To evaluate the efficacy of obefazimod on CS-free clinical remission (clinical remission at Year 4 and corticosteroid free for at least 12 weeks prior to Year 4 in the subpopulation with corticosteroids at maintenance study entry)
Query!
Timepoint [9]
0
0
LTE Year 4
Query!
Secondary outcome [10]
0
0
LTE Phase - Proportion of subjects with endoscopic improvement at LTE Year 1
Query!
Assessment method [10]
0
0
To evaluate the efficacy of obefazimod on endoscopic improvement (Mayo Endoscopic Subscore (MES) = 0 or 1)
Query!
Timepoint [10]
0
0
LTE Year 1
Query!
Secondary outcome [11]
0
0
LTE Phase - Proportion of subjects with endoscopic improvement at LTE Year 4
Query!
Assessment method [11]
0
0
To evaluate the efficacy of obefazimod on endoscopic improvement (Mayo Endoscopic Subscore (MES) = 0 or 1)
Query!
Timepoint [11]
0
0
LTE Year 4
Query!
Secondary outcome [12]
0
0
LTE Phase - Proportion of subjects with endoscopic remission at LTE year 1
Query!
Assessment method [12]
0
0
To evaluate the efficacy of obefazimod on endoscopic remission ((Mayo Endoscopic Subscore (MES) = 0)
Query!
Timepoint [12]
0
0
LTE year 1
Query!
Secondary outcome [13]
0
0
LTE Phase - Proportion of subjects with endoscopic remission at LTE year 4
Query!
Assessment method [13]
0
0
To evaluate the efficacy of obefazimod on endoscopic remission (Mayo Endoscopic Subscore (MES) = 0)
Query!
Timepoint [13]
0
0
LTE year 4
Query!
Secondary outcome [14]
0
0
LTE Phase - Proportion of subjects with CS-free symptomatic remission by visit
Query!
Assessment method [14]
0
0
To evaluate the efficacy of obefazimod on CS-free symptomatic remission (symptomatic remission (SFS = 0 or 1 and RBS = 0) and corticosteroid free for at least 12 weeks prior to Week 44 in the subpopulation with corticosteroids at maintenance study entry) by visit (every 3-month)
Query!
Timepoint [14]
0
0
4 years
Query!
Secondary outcome [15]
0
0
LTE Phase - Proportion of subjects with HEMI per Geboes scoring at LTE Year 1
Query!
Assessment method [15]
0
0
To evaluate the efficacy of obefazimod on histologic endoscopic mucosal improvement (HEMI) per Geboes scoring
Query!
Timepoint [15]
0
0
LTE Year 1
Query!
Secondary outcome [16]
0
0
LTE Phase - Proportion of subjects with HEMI per Geboes scoring at LTE Year 4
Query!
Assessment method [16]
0
0
To evaluate the efficacy of obefazimod on histologic endoscopic mucosal improvement (HEMI) per Geboes scoring
Query!
Timepoint [16]
0
0
LTE Year 4
Query!
Secondary outcome [17]
0
0
LTE Phase - Proportion of subjects with HEMR per Geboes scoring at LTE Year 1
Query!
Assessment method [17]
0
0
To evaluate the efficacy of obefazimod on histologic endoscopic mucosal remission (HEMR) versus placebo
Query!
Timepoint [17]
0
0
LTE Year 1
Query!
Secondary outcome [18]
0
0
LTE Phase - Proportion of subjects with HEMR per Geboes scoring at LTE Year 4
Query!
Assessment method [18]
0
0
To evaluate the efficacy of obefazimod on histologic endoscopic mucosal remission (HEMR) versus placebo
Query!
Timepoint [18]
0
0
LTE Year 4
Query!
Secondary outcome [19]
0
0
LTE Phase - Proportion of subjects with sustained clinical remission at LTE Year 1, in the sub-population of subjects with clinical remission at Week 44
Query!
Assessment method [19]
0
0
To evaluate the efficacy of obefazimod on sustained clinical remission Sustained clinical remission for the LTE is defined as clinical remission assessed at an endoscopy visit during the LTE in the sub-population of subjects in clinical remission at Week 44.
Query!
Timepoint [19]
0
0
LTE Year 1
Query!
Secondary outcome [20]
0
0
LTE Phase - Proportion of subjects with sustained clinical remission at LTE year 4, in the sub-population of subjects with clinical remission at Week 44
Query!
Assessment method [20]
0
0
To evaluate the efficacy of obefazimod on sustained clinical remission Sustained clinical remission for the LTE is defined as clinical remission assessed at an endoscopy visit during the LTE in the sub-population of subjects in clinical remission at Week 44.
Query!
Timepoint [20]
0
0
LTE year 4
Query!
Secondary outcome [21]
0
0
LTE Phase - Proportion of subjects with sustained endoscopic improvement at LTE Year 1, in the sub-population of subjects with endoscopic improvement at Week 44
Query!
Assessment method [21]
0
0
To evaluate the efficacy of obefazimod on sustained endoscopic improvement
Query!
Timepoint [21]
0
0
LTE Year 1
Query!
Secondary outcome [22]
0
0
LTE Phase - Proportion of subjects with sustained endoscopic improvement at LTE Year 4, in the sub-population of subjects with endoscopic improvement at Week 44
Query!
Assessment method [22]
0
0
To evaluate the efficacy of obefazimod on sustained endoscopic improvement
Query!
Timepoint [22]
0
0
LTE year 4
Query!
Secondary outcome [23]
0
0
LTE Phase - Proportion of subjects with symptomatic remission by visit
Query!
Assessment method [23]
0
0
To evaluate the efficacy of obefazimod on symptomatic remission (SFS = 0 or 1 and RBS = 0) by visit (every 3-month)
Query!
Timepoint [23]
0
0
4 years
Query!
Secondary outcome [24]
0
0
LTE Phase - Proportion of subjects with sustained symptomatic remission by visit
Query!
Assessment method [24]
0
0
To evaluate the efficacy of obefazimod on sustained symptomatic remission (SFS = 0 or 1 and RBS = 0) by visit (every 3-month), in the sub-population of subjects with symptomatic remission at Week 44
Query!
Timepoint [24]
0
0
4 years
Query!
Secondary outcome [25]
0
0
LTE Phase - Proportion of subjects with CS-free clinical remission at LTE Year 1
Query!
Assessment method [25]
0
0
To evaluate the efficacy of obefazimod on CS-free clinical remission (clinical remission at Year 1 and CS-free for at least 12 weeks immediately prior to Year 1)
Query!
Timepoint [25]
0
0
LTE Year 1
Query!
Secondary outcome [26]
0
0
LTE Phase - Proportion of subjects with CS-free clinical remission at LTE Year 4
Query!
Assessment method [26]
0
0
To evaluate the efficacy of obefazimod on CS-free clinical remission (clinical remission at Year 4 and CS-free for at least 12 weeks immediately prior to Year 4)
Query!
Timepoint [26]
0
0
LTE Year 4
Query!
Eligibility
Key inclusion criteria
Inclusion Criteria in maintenance phase:
* Subjects must have completed the induction treatment study (ABX464-105 or ABX464-106), and patients' clinical response status must be available.
* Subjects with a valid endoscopy performed at the end of the induction study and results from central reader available at Day 1.
* Subjects must understand, sign and date the written voluntary informed consent form at the visit prior to any protocol-specific procedures. For under-aged subjects, national requirements regarding consent should also be met.
* Women of childbearing potential (WOCBP) subjects and male subjects with WOCBP partner must agree to comply with contraception requirements as described in Section 4.4. (Contraception) of the protocol.
* Subjects must be able and willing to comply with study visits and procedures as per protocol.
* Subjects should be affiliated to a health insurance policy whenever required by a participating country or state
Inclusion criteria in LTE phase:
* Subject must have completed the maintenance phase
* Investigator and subject must assess and agree that the subject has received, and will continue to receive benefit from being in the study
Query!
Minimum age
16
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion Criteria in maintenance phase:
* Subjects who permanently discontinued the study treatment during the induction study (either ABX464-105 or ABX464-106).
* Subjects who have developed any major illness/condition (eg. primary sclerosis cholangitis, Crohn's disease, colectomy, diverting ileostomy, colon cancer or colonic adenomas [low or high grade dysplasia]).
* Subjects with evidence of an unstable clinical condition (eg. toxic megacolon, fulminant colitis, bowel perforation, uncontrolled ischemic disease, congestive heart failure with NYHA class 3 or 4 symptoms) during the induction study that, in the investigator's judgment, will substantially increase the risk to the subject if he or she participates in the study.
* Subjects who plan to participate in other investigational studies during the maintenance study.
* Male or female planning a pregnancy, or pregnant female subjects
* Introduction during induction study of prohibited medications, dosages, surgical or non-medicinal procedures indicated for UC (except antidiarrheals and motility agents for acute diarrhea).
* Any changes in the laboratory values during the induction period that could jeopardize subject's safety in the opinion of the investigator. If any doubts, the investigator should contact the sponsor study medical monitor.
* Subject who is planning to receive live vaccine during the study.
* Subjects committed to an institution by virtue of an order issued either by the judicial or the administrative authorities.
Exclusion criteria for LTE phase:
* Subject continues to satisfy exclusion criteria listed above for the maintenance phase
* Introduction during maintenance phase of prohibited medications, dosages, surgical or non-medicinal procedures indicated for UC (except antidiarrheals and motility agents for acute diarrhea).
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
16/01/2023
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
1/01/2030
Query!
Actual
Query!
Sample size
Target
1050
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,VIC
Query!
Recruitment hospital [1]
0
0
Blacktown Hospital - Blacktown
Query!
Recruitment hospital [2]
0
0
Concord Repatriation General Hospital - Concord
Query!
Recruitment hospital [3]
0
0
Liverpool Hospital - Liverpool
Query!
Recruitment hospital [4]
0
0
Royal Brisbane and Women's Hospital - Herston
Query!
Recruitment hospital [5]
0
0
Coral Sea Clinical Research Institute - North Mackay
Query!
Recruitment hospital [6]
0
0
Mater Hospital Brisbane - South Brisbane
Query!
Recruitment hospital [7]
0
0
Princess Alexandra Hospital - Woolloongabba
Query!
Recruitment hospital [8]
0
0
Box Hill Hospital - Box Hill
Query!
Recruitment hospital [9]
0
0
St Vincent's Hospital Melbourne - Fitzroy
Query!
Recruitment hospital [10]
0
0
Footscray Hospital - Footscray
Query!
Recruitment hospital [11]
0
0
Austin Health - Heidelberg
Query!
Recruitment hospital [12]
0
0
The Alfred Hospital - Melbourne
Query!
Recruitment hospital [13]
0
0
Royal Melbourne Hospital - Parkville
Query!
Recruitment postcode(s) [1]
0
0
2148 - Blacktown
Query!
Recruitment postcode(s) [2]
0
0
2139 - Concord
Query!
Recruitment postcode(s) [3]
0
0
2170 - Liverpool
Query!
Recruitment postcode(s) [4]
0
0
4029 - Herston
Query!
Recruitment postcode(s) [5]
0
0
4740 - North Mackay
Query!
Recruitment postcode(s) [6]
0
0
4101 - South Brisbane
Query!
Recruitment postcode(s) [7]
0
0
4102 - Woolloongabba
Query!
Recruitment postcode(s) [8]
0
0
3128 - Box Hill
Query!
Recruitment postcode(s) [9]
0
0
3065 - Fitzroy
Query!
Recruitment postcode(s) [10]
0
0
3011 - Footscray
Query!
Recruitment postcode(s) [11]
0
0
3084 - Heidelberg
Query!
Recruitment postcode(s) [12]
0
0
3004 - Melbourne
Query!
Recruitment postcode(s) [13]
0
0
3050 - Parkville
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Alabama
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Arizona
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Arkansas
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
California
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Colorado
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Connecticut
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Florida
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Georgia
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Illinois
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Indiana
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Iowa
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Kansas
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Kentucky
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Louisiana
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
Maryland
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Massachusetts
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
Michigan
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
Mississippi
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
Missouri
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
Nebraska
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
New Hampshire
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
New Jersey
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
New York
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
North Carolina
Query!
Country [25]
0
0
United States of America
Query!
State/province [25]
0
0
North Dakota
Query!
Country [26]
0
0
United States of America
Query!
State/province [26]
0
0
Ohio
Query!
Country [27]
0
0
United States of America
Query!
State/province [27]
0
0
Oklahoma
Query!
Country [28]
0
0
United States of America
Query!
State/province [28]
0
0
Pennsylvania
Query!
Country [29]
0
0
United States of America
Query!
State/province [29]
0
0
South Carolina
Query!
Country [30]
0
0
United States of America
Query!
State/province [30]
0
0
South Dakota
Query!
Country [31]
0
0
United States of America
Query!
State/province [31]
0
0
Tennessee
Query!
Country [32]
0
0
United States of America
Query!
State/province [32]
0
0
Texas
Query!
Country [33]
0
0
United States of America
Query!
State/province [33]
0
0
Utah
Query!
Country [34]
0
0
United States of America
Query!
State/province [34]
0
0
Virginia
Query!
Country [35]
0
0
United States of America
Query!
State/province [35]
0
0
Washington
Query!
Country [36]
0
0
Argentina
Query!
State/province [36]
0
0
Buenos Aires
Query!
Country [37]
0
0
Argentina
Query!
State/province [37]
0
0
Cordoba
Query!
Country [38]
0
0
Argentina
Query!
State/province [38]
0
0
Tucuman
Query!
Country [39]
0
0
Austria
Query!
State/province [39]
0
0
Graz
Query!
Country [40]
0
0
Austria
Query!
State/province [40]
0
0
Innsbruck
Query!
Country [41]
0
0
Austria
Query!
State/province [41]
0
0
Linz
Query!
Country [42]
0
0
Austria
Query!
State/province [42]
0
0
Salzburg
Query!
Country [43]
0
0
Austria
Query!
State/province [43]
0
0
St Veit an der Glan
Query!
Country [44]
0
0
Belgium
Query!
State/province [44]
0
0
Antwerpen
Query!
Country [45]
0
0
Belgium
Query!
State/province [45]
0
0
Brasschaat
Query!
Country [46]
0
0
Belgium
Query!
State/province [46]
0
0
Brussel
Query!
Country [47]
0
0
Belgium
Query!
State/province [47]
0
0
Bruxelles
Query!
Country [48]
0
0
Belgium
Query!
State/province [48]
0
0
Gent
Query!
Country [49]
0
0
Belgium
Query!
State/province [49]
0
0
Leuven
Query!
Country [50]
0
0
Belgium
Query!
State/province [50]
0
0
Liège
Query!
Country [51]
0
0
Belgium
Query!
State/province [51]
0
0
Roeselare
Query!
Country [52]
0
0
Belgium
Query!
State/province [52]
0
0
Yvoir
Query!
Country [53]
0
0
Brazil
Query!
State/province [53]
0
0
Bahia
Query!
Country [54]
0
0
Brazil
Query!
State/province [54]
0
0
Distrito Federal
Query!
Country [55]
0
0
Brazil
Query!
State/province [55]
0
0
Minas Gerais
Query!
Country [56]
0
0
Brazil
Query!
State/province [56]
0
0
Paraná
Query!
Country [57]
0
0
Brazil
Query!
State/province [57]
0
0
Rio Grande Do Sul
Query!
Country [58]
0
0
Brazil
Query!
State/province [58]
0
0
Sao Paulo
Query!
Country [59]
0
0
Bulgaria
Query!
State/province [59]
0
0
Pleven
Query!
Country [60]
0
0
Bulgaria
Query!
State/province [60]
0
0
Sofia
Query!
Country [61]
0
0
Bulgaria
Query!
State/province [61]
0
0
Veliko Tarnovo
Query!
Country [62]
0
0
Canada
Query!
State/province [62]
0
0
Alberta
Query!
Country [63]
0
0
Canada
Query!
State/province [63]
0
0
British Columbia
Query!
Country [64]
0
0
Canada
Query!
State/province [64]
0
0
Ontario
Query!
Country [65]
0
0
Canada
Query!
State/province [65]
0
0
Quebec
Query!
Country [66]
0
0
China
Query!
State/province [66]
0
0
Anhui
Query!
Country [67]
0
0
China
Query!
State/province [67]
0
0
Beijing
Query!
Country [68]
0
0
China
Query!
State/province [68]
0
0
Fujian
Query!
Country [69]
0
0
China
Query!
State/province [69]
0
0
Guangdong
Query!
Country [70]
0
0
China
Query!
State/province [70]
0
0
Guangzhou
Query!
Country [71]
0
0
China
Query!
State/province [71]
0
0
Henan
Query!
Country [72]
0
0
China
Query!
State/province [72]
0
0
Hubei
Query!
Country [73]
0
0
China
Query!
State/province [73]
0
0
Hunan
Query!
Country [74]
0
0
China
Query!
State/province [74]
0
0
Jiangsu
Query!
Country [75]
0
0
China
Query!
State/province [75]
0
0
Jiangxi
Query!
Country [76]
0
0
China
Query!
State/province [76]
0
0
Jilin
Query!
Country [77]
0
0
China
Query!
State/province [77]
0
0
Liaoning
Query!
Country [78]
0
0
China
Query!
State/province [78]
0
0
Shandong
Query!
Country [79]
0
0
China
Query!
State/province [79]
0
0
Shanghai
Query!
Country [80]
0
0
China
Query!
State/province [80]
0
0
Tianjin
Query!
Country [81]
0
0
China
Query!
State/province [81]
0
0
Yunnan
Query!
Country [82]
0
0
China
Query!
State/province [82]
0
0
Zhejiang
Query!
Country [83]
0
0
Croatia
Query!
State/province [83]
0
0
Koprivnica
Query!
Country [84]
0
0
Croatia
Query!
State/province [84]
0
0
Osijek
Query!
Country [85]
0
0
Croatia
Query!
State/province [85]
0
0
Zagreb
Query!
Country [86]
0
0
Czechia
Query!
State/province [86]
0
0
Brno
Query!
Country [87]
0
0
Czechia
Query!
State/province [87]
0
0
Hradec Kralove
Query!
Country [88]
0
0
Czechia
Query!
State/province [88]
0
0
Olomouc
Query!
Country [89]
0
0
Czechia
Query!
State/province [89]
0
0
Ostrava
Query!
Country [90]
0
0
Czechia
Query!
State/province [90]
0
0
Praha 4
Query!
Country [91]
0
0
Czechia
Query!
State/province [91]
0
0
Slaný
Query!
Country [92]
0
0
France
Query!
State/province [92]
0
0
Alpes Maritimes
Query!
Country [93]
0
0
France
Query!
State/province [93]
0
0
Ardennes
Query!
Country [94]
0
0
France
Query!
State/province [94]
0
0
Bouches-du-Rhône
Query!
Country [95]
0
0
France
Query!
State/province [95]
0
0
Calvados
Query!
Country [96]
0
0
France
Query!
State/province [96]
0
0
Cote dÝOr
Query!
Country [97]
0
0
France
Query!
State/province [97]
0
0
Doubs
Query!
Country [98]
0
0
France
Query!
State/province [98]
0
0
Gironde
Query!
Country [99]
0
0
France
Query!
State/province [99]
0
0
Haute Garonne
Query!
Country [100]
0
0
France
Query!
State/province [100]
0
0
Hauts De Seine
Query!
Country [101]
0
0
France
Query!
State/province [101]
0
0
Herault
Query!
Country [102]
0
0
France
Query!
State/province [102]
0
0
Ille Et Vilaine
Query!
Country [103]
0
0
France
Query!
State/province [103]
0
0
Isère
Query!
Country [104]
0
0
France
Query!
State/province [104]
0
0
Loire Atlantique
Query!
Country [105]
0
0
France
Query!
State/province [105]
0
0
Loire
Query!
Country [106]
0
0
France
Query!
State/province [106]
0
0
Meurthe Et Moselle
Query!
Country [107]
0
0
France
Query!
State/province [107]
0
0
Nord
Query!
Country [108]
0
0
France
Query!
State/province [108]
0
0
Puy De Dome
Query!
Country [109]
0
0
France
Query!
State/province [109]
0
0
Pyrenees Atlantiques
Query!
Country [110]
0
0
France
Query!
State/province [110]
0
0
Rhone
Query!
Country [111]
0
0
France
Query!
State/province [111]
0
0
Somme
Query!
Country [112]
0
0
France
Query!
State/province [112]
0
0
Val De Marne
Query!
Country [113]
0
0
France
Query!
State/province [113]
0
0
Vendée
Query!
Country [114]
0
0
France
Query!
State/province [114]
0
0
Paris
Query!
Country [115]
0
0
Germany
Query!
State/province [115]
0
0
Baden Wuerttemberg
Query!
Country [116]
0
0
Germany
Query!
State/province [116]
0
0
Bayern
Query!
Country [117]
0
0
Germany
Query!
State/province [117]
0
0
Hessen
Query!
Country [118]
0
0
Germany
Query!
State/province [118]
0
0
Niedersachsen
Query!
Country [119]
0
0
Germany
Query!
State/province [119]
0
0
Rheinland Pfalz
Query!
Country [120]
0
0
Germany
Query!
State/province [120]
0
0
Schleswig Holstein
Query!
Country [121]
0
0
Germany
Query!
State/province [121]
0
0
Berlin
Query!
Country [122]
0
0
Germany
Query!
State/province [122]
0
0
Hamburg
Query!
Country [123]
0
0
Greece
Query!
State/province [123]
0
0
Athens
Query!
Country [124]
0
0
Greece
Query!
State/province [124]
0
0
Corfu
Query!
Country [125]
0
0
Greece
Query!
State/province [125]
0
0
Heraklion
Query!
Country [126]
0
0
Greece
Query!
State/province [126]
0
0
Thessaloníki
Query!
Country [127]
0
0
Hungary
Query!
State/province [127]
0
0
Budapest
Query!
Country [128]
0
0
Hungary
Query!
State/province [128]
0
0
Békéscsaba
Query!
Country [129]
0
0
Hungary
Query!
State/province [129]
0
0
Gyongyos
Query!
Country [130]
0
0
Hungary
Query!
State/province [130]
0
0
Szekszard
Query!
Country [131]
0
0
India
Query!
State/province [131]
0
0
Andhra Pradesh
Query!
Country [132]
0
0
India
Query!
State/province [132]
0
0
Delhi
Query!
Country [133]
0
0
India
Query!
State/province [133]
0
0
Gujarat
Query!
Country [134]
0
0
India
Query!
State/province [134]
0
0
Haryana
Query!
Country [135]
0
0
India
Query!
State/province [135]
0
0
Karnataka
Query!
Country [136]
0
0
India
Query!
State/province [136]
0
0
Kerala
Query!
Country [137]
0
0
India
Query!
State/province [137]
0
0
Maharashtra
Query!
Country [138]
0
0
India
Query!
State/province [138]
0
0
Punjab
Query!
Country [139]
0
0
India
Query!
State/province [139]
0
0
Rajasthan
Query!
Country [140]
0
0
India
Query!
State/province [140]
0
0
Tamilnadu
Query!
Country [141]
0
0
India
Query!
State/province [141]
0
0
Uttar Pradesh
Query!
Country [142]
0
0
India
Query!
State/province [142]
0
0
West Bengal
Query!
Country [143]
0
0
India
Query!
State/province [143]
0
0
Chandigarh
Query!
Country [144]
0
0
Ireland
Query!
State/province [144]
0
0
Westmeath
Query!
Country [145]
0
0
Ireland
Query!
State/province [145]
0
0
Dublin
Query!
Country [146]
0
0
Ireland
Query!
State/province [146]
0
0
Galway
Query!
Country [147]
0
0
Ireland
Query!
State/province [147]
0
0
Louth
Query!
Country [148]
0
0
Israel
Query!
State/province [148]
0
0
Afula
Query!
Country [149]
0
0
Israel
Query!
State/province [149]
0
0
Be'er Sheva
Query!
Country [150]
0
0
Israel
Query!
State/province [150]
0
0
Haifa
Query!
Country [151]
0
0
Israel
Query!
State/province [151]
0
0
Holon
Query!
Country [152]
0
0
Israel
Query!
State/province [152]
0
0
Jerusalem
Query!
Country [153]
0
0
Israel
Query!
State/province [153]
0
0
Kfar- Sava
Query!
Country [154]
0
0
Israel
Query!
State/province [154]
0
0
Petach Tikva
Query!
Country [155]
0
0
Israel
Query!
State/province [155]
0
0
Ramat Gan
Query!
Country [156]
0
0
Israel
Query!
State/province [156]
0
0
Rehovot
Query!
Country [157]
0
0
Israel
Query!
State/province [157]
0
0
Tel Aviv
Query!
Country [158]
0
0
Italy
Query!
State/province [158]
0
0
Foggia
Query!
Country [159]
0
0
Italy
Query!
State/province [159]
0
0
Milano
Query!
Country [160]
0
0
Italy
Query!
State/province [160]
0
0
Verona
Query!
Country [161]
0
0
Italy
Query!
State/province [161]
0
0
Alessandria
Query!
Country [162]
0
0
Italy
Query!
State/province [162]
0
0
Bologna
Query!
Country [163]
0
0
Italy
Query!
State/province [163]
0
0
Brescia
Query!
Country [164]
0
0
Italy
Query!
State/province [164]
0
0
Cagliari
Query!
Country [165]
0
0
Italy
Query!
State/province [165]
0
0
Catania
Query!
Country [166]
0
0
Italy
Query!
State/province [166]
0
0
Catanzaro
Query!
Country [167]
0
0
Italy
Query!
State/province [167]
0
0
Napoli
Query!
Country [168]
0
0
Italy
Query!
State/province [168]
0
0
Padova
Query!
Country [169]
0
0
Italy
Query!
State/province [169]
0
0
Palermo
Query!
Country [170]
0
0
Italy
Query!
State/province [170]
0
0
Pavia
Query!
Country [171]
0
0
Italy
Query!
State/province [171]
0
0
Pisa
Query!
Country [172]
0
0
Italy
Query!
State/province [172]
0
0
Roma
Query!
Country [173]
0
0
Italy
Query!
State/province [173]
0
0
Udine
Query!
Country [174]
0
0
Italy
Query!
State/province [174]
0
0
Vicenza
Query!
Country [175]
0
0
Japan
Query!
State/province [175]
0
0
Aichi-Ken
Query!
Country [176]
0
0
Japan
Query!
State/province [176]
0
0
Chiba-Ken
Query!
Country [177]
0
0
Japan
Query!
State/province [177]
0
0
Ehime-Ken
Query!
Country [178]
0
0
Japan
Query!
State/province [178]
0
0
Fukuoka-Ken
Query!
Country [179]
0
0
Japan
Query!
State/province [179]
0
0
Gunma-Ken
Query!
Country [180]
0
0
Japan
Query!
State/province [180]
0
0
Hiroshima-Ken
Query!
Country [181]
0
0
Japan
Query!
State/province [181]
0
0
Hokkaido
Query!
Country [182]
0
0
Japan
Query!
State/province [182]
0
0
Hyogo-Ken
Query!
Country [183]
0
0
Japan
Query!
State/province [183]
0
0
Ishikawa-Ken
Query!
Country [184]
0
0
Japan
Query!
State/province [184]
0
0
Kagawa-Ken
Query!
Country [185]
0
0
Japan
Query!
State/province [185]
0
0
Kagoshima-Ken
Query!
Country [186]
0
0
Japan
Query!
State/province [186]
0
0
Kanagawa-Ken
Query!
Country [187]
0
0
Japan
Query!
State/province [187]
0
0
Kumamoto-Ken
Query!
Country [188]
0
0
Japan
Query!
State/province [188]
0
0
Mie-Ken
Query!
Country [189]
0
0
Japan
Query!
State/province [189]
0
0
Niigata-Ken
Query!
Country [190]
0
0
Japan
Query!
State/province [190]
0
0
Oita-Ken
Query!
Country [191]
0
0
Japan
Query!
State/province [191]
0
0
Okayama-Ken
Query!
Country [192]
0
0
Japan
Query!
State/province [192]
0
0
Okinawa-Ken
Query!
Country [193]
0
0
Japan
Query!
State/province [193]
0
0
Osaka-Fu
Query!
Country [194]
0
0
Japan
Query!
State/province [194]
0
0
Saga-Ken
Query!
Country [195]
0
0
Japan
Query!
State/province [195]
0
0
Saitama-Ken
Query!
Country [196]
0
0
Japan
Query!
State/province [196]
0
0
Shizuoka-Ken
Query!
Country [197]
0
0
Japan
Query!
State/province [197]
0
0
Tokyo-To
Query!
Country [198]
0
0
Japan
Query!
State/province [198]
0
0
Ibaraki
Query!
Country [199]
0
0
Korea, Republic of
Query!
State/province [199]
0
0
Chungcheongbuk-do
Query!
Country [200]
0
0
Korea, Republic of
Query!
State/province [200]
0
0
Gangwon-do
Query!
Country [201]
0
0
Korea, Republic of
Query!
State/province [201]
0
0
Gyeonggi-do
Query!
Country [202]
0
0
Korea, Republic of
Query!
State/province [202]
0
0
Gyeongsangbuk-do
Query!
Country [203]
0
0
Korea, Republic of
Query!
State/province [203]
0
0
Busan
Query!
Country [204]
0
0
Korea, Republic of
Query!
State/province [204]
0
0
Daegu
Query!
Country [205]
0
0
Korea, Republic of
Query!
State/province [205]
0
0
Daejeon
Query!
Country [206]
0
0
Korea, Republic of
Query!
State/province [206]
0
0
Incheon
Query!
Country [207]
0
0
Korea, Republic of
Query!
State/province [207]
0
0
Seoul
Query!
Country [208]
0
0
Lithuania
Query!
State/province [208]
0
0
Kaunas
Query!
Country [209]
0
0
Lithuania
Query!
State/province [209]
0
0
Klaipeda
Query!
Country [210]
0
0
Mexico
Query!
State/province [210]
0
0
Guanajuato
Query!
Country [211]
0
0
Mexico
Query!
State/province [211]
0
0
Nuevo León
Query!
Country [212]
0
0
Mexico
Query!
State/province [212]
0
0
Veracruz
Query!
Country [213]
0
0
Netherlands
Query!
State/province [213]
0
0
Amsterdam
Query!
Country [214]
0
0
Netherlands
Query!
State/province [214]
0
0
Geleen
Query!
Country [215]
0
0
Netherlands
Query!
State/province [215]
0
0
Nijmegen
Query!
Country [216]
0
0
Netherlands
Query!
State/province [216]
0
0
Rotterdam
Query!
Country [217]
0
0
Netherlands
Query!
State/province [217]
0
0
Tilburg
Query!
Country [218]
0
0
Netherlands
Query!
State/province [218]
0
0
Uden
Query!
Country [219]
0
0
Netherlands
Query!
State/province [219]
0
0
Utrecht
Query!
Country [220]
0
0
New Zealand
Query!
State/province [220]
0
0
Christchurch
Query!
Country [221]
0
0
New Zealand
Query!
State/province [221]
0
0
Dunedin
Query!
Country [222]
0
0
New Zealand
Query!
State/province [222]
0
0
Hamilton
Query!
Country [223]
0
0
New Zealand
Query!
State/province [223]
0
0
Tauranga
Query!
Country [224]
0
0
Poland
Query!
State/province [224]
0
0
Belchatow
Query!
Country [225]
0
0
Poland
Query!
State/province [225]
0
0
Bialystok
Query!
Country [226]
0
0
Poland
Query!
State/province [226]
0
0
Bydgoszcz
Query!
Country [227]
0
0
Poland
Query!
State/province [227]
0
0
Gdynia
Query!
Country [228]
0
0
Poland
Query!
State/province [228]
0
0
Kalisz
Query!
Country [229]
0
0
Poland
Query!
State/province [229]
0
0
Kielce
Query!
Country [230]
0
0
Poland
Query!
State/province [230]
0
0
Knurów
Query!
Country [231]
0
0
Poland
Query!
State/province [231]
0
0
Kraków
Query!
Country [232]
0
0
Poland
Query!
State/province [232]
0
0
Lublin
Query!
Country [233]
0
0
Poland
Query!
State/province [233]
0
0
Nowy Targ
Query!
Country [234]
0
0
Poland
Query!
State/province [234]
0
0
Olsztyn
Query!
Country [235]
0
0
Poland
Query!
State/province [235]
0
0
Opole
Query!
Country [236]
0
0
Poland
Query!
State/province [236]
0
0
Oswiecim
Query!
Country [237]
0
0
Poland
Query!
State/province [237]
0
0
Poznan
Query!
Country [238]
0
0
Poland
Query!
State/province [238]
0
0
Rzeszów
Query!
Country [239]
0
0
Poland
Query!
State/province [239]
0
0
Sosnowiec
Query!
Country [240]
0
0
Poland
Query!
State/province [240]
0
0
Staszów
Query!
Country [241]
0
0
Poland
Query!
State/province [241]
0
0
Szczecin
Query!
Country [242]
0
0
Poland
Query!
State/province [242]
0
0
Tarnów
Query!
Country [243]
0
0
Poland
Query!
State/province [243]
0
0
Warsaw
Query!
Country [244]
0
0
Poland
Query!
State/province [244]
0
0
Warszawa
Query!
Country [245]
0
0
Poland
Query!
State/province [245]
0
0
Wroclaw
Query!
Country [246]
0
0
Poland
Query!
State/province [246]
0
0
Zamosc
Query!
Country [247]
0
0
Poland
Query!
State/province [247]
0
0
Lódz
Query!
Country [248]
0
0
Poland
Query!
State/province [248]
0
0
Leczna
Query!
Country [249]
0
0
Poland
Query!
State/province [249]
0
0
Swidnica
Query!
Country [250]
0
0
Portugal
Query!
State/province [250]
0
0
Braga
Query!
Country [251]
0
0
Portugal
Query!
State/province [251]
0
0
Guimarães
Query!
Country [252]
0
0
Portugal
Query!
State/province [252]
0
0
Lisboa
Query!
Country [253]
0
0
Portugal
Query!
State/province [253]
0
0
Santa Maria Da Feira
Query!
Country [254]
0
0
Portugal
Query!
State/province [254]
0
0
Viana Do Castelo
Query!
Country [255]
0
0
Romania
Query!
State/province [255]
0
0
Bucharest
Query!
Country [256]
0
0
Romania
Query!
State/province [256]
0
0
Bucuresti
Query!
Country [257]
0
0
Romania
Query!
State/province [257]
0
0
Cluj-Napoca
Query!
Country [258]
0
0
Romania
Query!
State/province [258]
0
0
Craiova
Query!
Country [259]
0
0
Romania
Query!
State/province [259]
0
0
Oradea
Query!
Country [260]
0
0
Romania
Query!
State/province [260]
0
0
Ploiesti
Query!
Country [261]
0
0
Serbia
Query!
State/province [261]
0
0
Belgrade
Query!
Country [262]
0
0
Serbia
Query!
State/province [262]
0
0
Kragujevac
Query!
Country [263]
0
0
Serbia
Query!
State/province [263]
0
0
Subotica
Query!
Country [264]
0
0
Serbia
Query!
State/province [264]
0
0
Zrenjanin
Query!
Country [265]
0
0
Slovakia
Query!
State/province [265]
0
0
Banská Bystrica
Query!
Country [266]
0
0
Slovakia
Query!
State/province [266]
0
0
Bratislava
Query!
Country [267]
0
0
Slovakia
Query!
State/province [267]
0
0
Košice
Query!
Country [268]
0
0
Slovakia
Query!
State/province [268]
0
0
Nitra
Query!
Country [269]
0
0
Slovakia
Query!
State/province [269]
0
0
Prešov
Query!
Country [270]
0
0
Slovakia
Query!
State/province [270]
0
0
Å ahy
Query!
Country [271]
0
0
Spain
Query!
State/province [271]
0
0
Cordoba
Query!
Country [272]
0
0
Spain
Query!
State/province [272]
0
0
La Coruña
Query!
Country [273]
0
0
Spain
Query!
State/province [273]
0
0
Las Palmas
Query!
Country [274]
0
0
Spain
Query!
State/province [274]
0
0
Madrid
Query!
Country [275]
0
0
Spain
Query!
State/province [275]
0
0
Barcelona
Query!
Country [276]
0
0
Spain
Query!
State/province [276]
0
0
Girona
Query!
Country [277]
0
0
Spain
Query!
State/province [277]
0
0
Huelva
Query!
Country [278]
0
0
Spain
Query!
State/province [278]
0
0
Pontevedra
Query!
Country [279]
0
0
Spain
Query!
State/province [279]
0
0
Sevilla
Query!
Country [280]
0
0
Spain
Query!
State/province [280]
0
0
Valencia
Query!
Country [281]
0
0
Spain
Query!
State/province [281]
0
0
Zaragoza
Query!
Country [282]
0
0
Switzerland
Query!
State/province [282]
0
0
Basel
Query!
Country [283]
0
0
Switzerland
Query!
State/province [283]
0
0
Bern
Query!
Country [284]
0
0
Switzerland
Query!
State/province [284]
0
0
Zuerich
Query!
Country [285]
0
0
Turkey
Query!
State/province [285]
0
0
Ankara
Query!
Country [286]
0
0
Turkey
Query!
State/province [286]
0
0
Antalya
Query!
Country [287]
0
0
Turkey
Query!
State/province [287]
0
0
Istanbul
Query!
Country [288]
0
0
Turkey
Query!
State/province [288]
0
0
Izmir
Query!
Country [289]
0
0
Turkey
Query!
State/province [289]
0
0
Kocaeli
Query!
Country [290]
0
0
Turkey
Query!
State/province [290]
0
0
Malatya
Query!
Country [291]
0
0
Turkey
Query!
State/province [291]
0
0
Mersin
Query!
Country [292]
0
0
United Kingdom
Query!
State/province [292]
0
0
Cambridgeshire
Query!
Country [293]
0
0
United Kingdom
Query!
State/province [293]
0
0
Devon
Query!
Country [294]
0
0
United Kingdom
Query!
State/province [294]
0
0
Greater London
Query!
Country [295]
0
0
United Kingdom
Query!
State/province [295]
0
0
Greater Manchester
Query!
Country [296]
0
0
United Kingdom
Query!
State/province [296]
0
0
Middlesex
Query!
Country [297]
0
0
United Kingdom
Query!
State/province [297]
0
0
Somerset
Query!
Country [298]
0
0
United Kingdom
Query!
State/province [298]
0
0
West Yorkshire
Query!
Country [299]
0
0
United Kingdom
Query!
State/province [299]
0
0
Belfast
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Abivax S.A.
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This is a multicenter, randomized, placebo-controlled study to evaluate the long-term efficacy and safety of ABX464 50mg and 25mg administered once daily (QD) as maintenance therapy in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\]. This study is the maintenance phase of both previous induction studies ABX464-105 and ABX464-106.
Query!
Trial website
https://clinicaltrials.gov/study/NCT05535946
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Severine Vermeire, MD, PhD
Query!
Address
0
0
UZ Leuven, Belgium
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Laurence Desroys du Roure, PharmD
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
+33630031132
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT05535946
Download to PDF